Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer

Oral Diseases

Volumn 16, Issue 4, 2010, Pages 360-364

  Liu, C J ^a,b,c   Kao, S Y ^a   Tu, H F ^a   Tsai, M M ^a   Chang, K W ^a,d   Lin, S C ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Carcinoma; Marker; MiR 31; Oral; Plasma; Saliva

Indexed keywords

MICRORNA; MICRORNA 31; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN31 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MOUTH CANCER; MOUTH CARCINOMA; PRIORITY JOURNAL; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SQUAMOUS CELL CARCINOMA; WILCOXON SIGNED RANKS TEST; AGED; BLOOD; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; MOUTH NEOPLASMS; NONPARAMETRIC TEST; REFERENCE VALUE; SALIVA; STATISTICAL ANALYSIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; REFERENCE VALUES; ROC CURVE; SALIVA; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 77950466208     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01646.x     Document Type: Article

References (32)

1. Bandres E, Cubedo E, Agirre X et al (2006). Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5 : 29.
2. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 : 281 297.
3. Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell 136 : 215 233.
4. Bijian K, Mlynarek AM, Balys RL et al (2009). Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J Proteome Res 8 : 2173 2185.
5. Chang KW, Liu CJ, Chu TH et al (2008a). Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 87 : 1063 1068.
6. Chang SS, Jiang WW, Smith I et al (2008b). MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123 : 2791 2797.
7. Chen X, Ba Y, Ma L et al (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18 : 997 1006.
8. Chen HC, Chen GH, Chen YH et al (2009). MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 100 : 1002 1011.
9. Cheng AJ, Chen LC, Chien KY et al (2005). Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51 : 2236 2244.
10. Dalmay T (2008). MicroRNAs and cancer. J Intern Med 263 : 366 375.
11. Dalmay T, Edwards DR (2006). MicroRNAs and the hallmarks of cancer. Oncogene 25 : 6170 6175.
12. Garcia-Olmo DC, Gutierrez-Gonzalez L, Samos J et al (2006). Surgery and hematogenous dissemination: comparison between the detection of circulating tumor cells and of tumor DNA in plasma before and after tumor resection in rats. Ann Surg Oncol 13 : 1136 1144.
13. Gilad S, Meiri E, Yogev Y et al (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE 3 : e3148.
14. Hu S, Arellano M, Boontheung P et al (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14 : 6246 6252.
15. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J (2008). Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68 : 2094 2105.
16. Li Y, St John MA, Zhou X et al (2004). Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 : 8442 8450.
17. Lin SC, Liu CJ, Ko SY et al (2005). Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers. J Pathol 206 : 417 422.
18. Liu CJ, Chang KW, Lin SC, Cheng HW (2009a). Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol 45 : 920 925.
19. Liu X, Chen Z, Yu J, Xia J, Zhou X (2009b). MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009 : 11 pp, ID 837514.
20. Mitchell PS, Parkin RK, Kroh EM et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105 : 10513 10518.
21. Nakamoto D, Yamamoto N, Takagi R et al (2006). Detection of tumor DNA in plasma using whole genome amplification. Bull Tokyo Dent Coll 47 : 125 131.
22. Ng EK, Chong WW, Jin H et al (2009a). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58 : 1375 1381.
23. Park NJ, Yu T, Nabili V et al (2006). RNAprotect saliva: an optimal room-temperature stabilization reagent for the salivary transcriptome. Clin Chem 52 : 2303 2304.
24. Park NJ, Zhou H, Elashoff D et al (2009). Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15 : 5473 5477.
25. Shieh TM, Lin SC, Liu CJ et al (2007). Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res 13 : 4378 4385.
26. Slaby O, Svoboda M, Fabian P et al (2007). Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72 : 397 402.
27. Tran N, McLean T, Zhang X et al (2007). MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 358 : 12 17.
28. Valastyan S, Reinhardt F, Benaich N et al (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137 : 1032 1046.
29. Wong QW, Lung RW, Law PT et al (2008a). MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135 : 257 269.
30. Wong TS, Liu XB, Wong BY et al (2008b). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14 : 2588 2592.
31. Yu J, Wang F, Yang GH et al (2006). Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 349 : 59 68.
32. Zhang Y, Guo J, Li D et al (2009). Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol, doi :.